CLINICAL TRIAL SUMMARY

MDACC Study No:2011-0691 (clinicaltrials.gov NCT No: NCT01511081)
Title:Randomized Phase II Study Comparing Stereotactic Body Radiotherapy (SBRT) with Stereotacic Body Proton Therapy (SBPT) for Centrally Located Stage I, Selected Stage II and Recurrent Non-Small Cell Lung Cancer
Principal Investigator:Joe Y. Chang
Treatment Agent:Stereotacic Body Proton Therapy; Stereotactic Radiotherapy
Study Status:Open
Study Description:The goal of this clinical research study is to compare 2 types of
radiotherapy, stereotactic body photon radiotherapy (SBRT) and stereotactic
body proton radiotherapy (SBPT). Researchers would like to compare the side
effects, quality of life, and cancer control.

Hide details for General InformationGeneral Information

Disease Group:Lung
Phase of Study:Phase II
Treatment Agents:Stereotacic Body Proton Therapy
Stereotactic Radiotherapy
Treatment Location:Both at MDACC & and Other Sites
Estimated Length of Stay in Houston:
Supported By:National Institute of Health (NIH)
Return Visit:
Home Care:


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Joe Y. Chang
Dept:Radiation Oncology
For Clinical Trial Enrollment:713-563-2300
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults